Hiroaki Fushimi

1.1k citations
75 papers · 742 indexed · h-index 15
Topics
Bladder and Urothelial Cancer Treatments (13 papers)Urinary and Genital Oncology Studies (12 papers)Neuroendocrine Tumor Research Advances (6 papers)
Partner nations
JapanUnited StatesTaiwan

In The Last Decade

Hiroaki Fushimi

66 papers receiving 720 citations

Peers

Hiroaki Fushimi
Comparison fields: 5 of 68
  • Surgery 342
  • Oncology 199
  • Pulmonary and Respiratory Medicine 169
  • Molecular Biology 142
  • Epidemiology 135
Replace Fernando Pinedo with:
Fernando Pinedo Spain
Maurizio Romano Italy
Şükrü Oğuz Özdamar Türkiye
Laura Marra Italy
Carsten Bramlage Germany
Masamichi Matsuda Japan
Yoji Yamazaki Japan
Chikao Yasunaga Japan
Ömür Ataoğlu Türkiye
Hamid Reza Foroutan Iran
Hiroaki Fushimi relative to Fernando Pinedo Spain Fernando Pinedo's profile →
Citations per field
00.5×2.5×
Fernando Pinedo · 1×
Citations per year

Countries citing papers authored by Hiroaki Fushimi

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Fushimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Fushimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Fushimi more than expected).

Fields of papers citing papers by Hiroaki Fushimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Fushimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Fushimi. The network helps show where Hiroaki Fushimi may publish in the future.

Co-authorship network of co-authors of Hiroaki Fushimi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Fushimi. A scholar is included among the top collaborators of Hiroaki Fushimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Fushimi. Hiroaki Fushimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 3
3 9
4 3
5 3
6 43
7 6
8 1
9 10
10 1
11 1
12 5
13 12
14 8
15 46
16 3
17 2
18 14
19 4
20 10

About Hiroaki Fushimi

Hiroaki Fushimi is a scholar working on Hepatology, Surgery and Oncology, having authored 75 papers that have together received 742 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (13 papers), Urinary and Genital Oncology Studies (12 papers) and Neuroendocrine Tumor Research Advances (6 papers). The work is most often cited by research in Hepatology (135 citations), Surgery (342 citations) and Oncology (199 citations). Hiroaki Fushimi has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Kazutoshi Fujita, Seiji Yamaguchi, Kiyoshi Kotoh, Norio Nonomura, George J. Netto, Hiroshi Miyamoto, Hiroki Ide, Satoshi Inoue, Taichi Mizushima and Hideyuki Fusamoto. Their work appears in journals such as PLoS ONE, Hepatology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026